The ratio of ENO1/MBP1 expression in cancer cells is regulated by glucose, with c-MYC-driven elevated ENO1 expression under high glucose conditions, and elevated MBP1 expression under low glucose conditions (Sedoris et al., 2007). The gene discussed is ENO1; the disease is cancer.